asthma ['æsmə]

asthma的基本解释

n.

哮喘

与asthma相关的网络例句 [注：此内容来源于网络，仅供参考]

The simultaneity use of Xiao Er Chuan Ke Ye and Cang Er Zi San intervening asthma and allergic rhinitis,comparing simply use Xiao Er Chuan Ke Ye,has the predominance in prolonging time of introducing asthma and reducing the frequency of nodding breathe,which indicated that the treatment of allergic rhinitis has great importance in asthma control and lessen the degree of asthma(frequency of rat nodding breath).3,The combination high-dose group has better therapeutic effect than dexamethasone group,all Chuan Ke Ye groups and combination low,medium group in the prevention and control of allergic rhinitis symptoms,reduced airway hyper responsiveness,while in improving breath difficulties combination high-dose group has similar effect with western medicine group,and better effect than all Chuan Ke Ye groups and combination low,medium group.Its efficacy increased with the prolonging of treatment time,but fewer side effects,which makes the application safer and more reliable.4,Xiao Er Chuan Ke Ye combining with Cang Er Zi San can obviously improve the pathological changes in rats with bronchial airway remodeling,reducing the serum TGF-β1,IL-4,ECP levels,increasing the level of serum IFN-γand the imbalance IFN-γ/ IL-4 ratio.

而运用小儿喘咳液合苍耳子散同时干预哮喘与过敏性鼻炎，较之单纯使用小儿喘咳液治疗哮喘，其在延长引喘时间、减少点头呼吸频度等方面有明显的优势，说明过敏性鼻炎的治疗，对于控制哮喘发生，减轻哮喘发作的程度，有着重要的意义。3、大剂量的合方在预防和控制过敏性鼻炎症状、降低哮喘气道高反应性方面疗效较地塞米松对照组、喘咳液各剂量组及合方小、中剂量组更优，而改善呼吸困难方面则与西药组相当，优于喘咳液各剂量组及合方小、中剂量组，且其疗效随着治疗时间的延长而增加，但副作用更少，使用更加安全可靠。4、小儿喘咳液合苍耳子散能明显改善气道重塑大鼠支气管的病理改变，同时降低血清TGF-β1、IL-4、ECP水平，提高血清IFN-γ水平及失衡的IFN-γ/IL-4比值。

The pathogenesis of asthma can be divided into three stages in immunology. The initial stage is sensibilization, which is closely associated with the activation of T cells. B7/CD28 and CD69 also play a significant role in this process. The second stage is chronic allergic inflammation. The immune dysfunction resulting from the disturbance of TH1/TH2 is a major cause of chronic allergic inflammation, and dominates asthma attack. And the third stage is airway remodeling due to chronic inflammation. Airway remodeling is one of the major causes of refractory asthma, which also contributes to the death from asthma.

哮喘的发病从免疫学角度可以分为三期：初期为致敏阶段，与T细胞激活关系密切，B7/CD28和CD69在这一过程也扮演重要角色；第二期为慢性过敏性炎症阶段，TH1/TH2失衡导致免疫功能紊乱是此阶段的主要原因，在哮喘发作过程中起主要作用；第三期为慢性炎症引起的气道结构重构阶段，是难治性支气管哮喘的重要发病和死亡原因。

For example, although the National Committee for Quality Assurance has found that more patients with asthma have been prescribed appropriate asthma mediations in recent years (71% in 2003 vs 63% in 2000), many children with asthma and their caregivers do not use preventive medications or know how to prevent or treat asthma attacks.

例如，虽然国家品质确保委员会发现，最近几年接受适当气喘药物处方的病患增加(从2000年的63%增加为2003年的71%)，仍有许多气喘小孩与其照护者没有使用预防性药物，或者不知道如何预防或治疗气喘发作。

与asthma相关的网络解释 [注：此内容来源于网络，仅供参考]

asthma：哮喘

MeSH词表就象一棵树的枝干,例如,"哮喘"(asthma)可以细分为"儿童性哮喘"(asthma in children)、"职业性哮喘"( occupational asthma)等等. Medline的索引编制人员被要求尽可能的使用最专业的MeSH术语来进行项目的标引.

asthma：气喘

对於承受於慢性的鼻窦炎(chronic sinustitis),气喘(asthma),支气管炎(bronchitis)、慢性阻塞性肺病(obstructive lung disesase),和其它呼吸道疾病的痛苦的人们而言,能尽情无碍的呼吸空气是多麼渴望的奢求.

asthma：哮喘病

一支国际性研究小组于近日发现一个关键基因,该基因与儿童时期的哮喘病(asthma)的发生有密切联系. 此项研究发表在了近日的>学术期刊上.

asthma：支气管哮喘

支气管哮喘(asthma)是一种全球性的严重威胁公众健康的常见疾病,并且发病率仍呈上升趋势,但对其发病机理还不完全明确. 近年来的研究发现,哮喘是一种以T淋巴细胞、嗜酸性粒细胞和肥大细胞等炎性细胞在气道浸润为特征的慢性气道炎症,

asthma paper：防喘纸

沥青原纸 asphalt base paper | 防喘纸 asthma paper | 地图纸 altas paper